News
Cancer immunotherapy represents a transformative approach in oncology, especially for treating cancers thought to be incurable. However, a significant ...
The authors present an important set of data implicating ETFDH as an epigenetically suppressed gene in cancer with tumor suppressive functions. The evidence is solid, with the authors demonstrating ...
Scientists have uncovered a promising new way to enhance the effectiveness of vaccines by tapping into the potential of a specific type of immune cell, opening the door to long-lasting vaccines for ...
1d
Barchart on MSNModerna Stock: Analyst Estimates & RatingsWith a market cap of $9.3 billion, Moderna, Inc. (MRNA) is a biotechnology company specializing in the development of messenger RNA (mRNA) therapeutics and vaccines. Known for its COVID-19 vaccine ...
Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...
A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
When director Cristina Costantini set out to make a documentary about Karol G’s record-breaking stadium tour, she knew she didn’t want to create a flashy publicity piece ...
StockStory.org on MSN4d
3 Cash-Heavy Stocks in the DoghouseCompanies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some ...
The U.S. stock rebound has gathered steam as the new month gets underway, confounding the old ’sell in May’ adage, largely ...
Meta Platforms (NASDAQ: META) stock climbed 6.2% after the Facebook and Instagram parent reported better-than-expected ...
We recently published a list of the 11 Worst Performing Stocks in S&P 500 So Far in 2025. In this article, we will take a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results